Axovant Sciences Ltd (AXGT)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

11-12 ST. JAMES'S SQUARE LONDON, UNITED KINGDOM SW1Y 4LB

Axovant Sciences Ltd. operates as a clinical-stage biopharmaceutical company. The Company focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurological disorders. Axovant Sciences develops products to treat the cognitive impairment and behavioral disturbances associated with dementia.

Data based on most recent fiscal year report
Market Cap128.175 Million Shares Outstanding107.71 Million Avg Volume1.759 Million
1-Yr BETA vs S&P TR Current Ratio4.75 Quick Ratio4.75
View SEC Filings from AXGT instead.
Q2 2019 All Institutions Hedge Funds 1
To trade AXGT now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 40 9 (0.93%)
Aggregate 13F shares on 06/30/2019: 3.071 Million 1.82 Million
Aggregate 13F shares on 03/31/2019: 4.861 Million 2.113 Million
Percent change: -36.83% -13.88%
Funds creating new positions: 5 2
Funds Adding to an existing position: 12 5
Funds closing out their position: 25 6
Funds reducing their position: 18 1
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AXGT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BICKERSTAFF GEORGE

  • Director
95,004 2019-10-01 1

CHERUVU PAVAN PRINCIPAL EXECUTIVE OFFICER

  • Officer
0 2019-09-21 3

CORCORAN GAVIN EVP OF R&D

  • Officer
0 2019-09-21 2

NASSIF DAVID W. PRINCIPAL FINANCIAL OFFICER

  • Officer
0 2019-09-21 3

VERNON W ANTHONY

  • Director
158,589 2019-08-29 0

POTTER MYRTLE S

  • Director
0 2019-08-23 2

TORTI FRANK

  • Director
0 2019-08-23 2

MACHADO PATRICK

  • Director
0 2019-07-31 3

QVT ASSOCIATES GP LLC

QVT FUND V LP

  • Director
  • 10% Owner
  • SEE REMARKSSEE REMARKS
0 2019-07-10 2

LO ANDREW

  • FORMER 10% OWNER
0 2019-07-10 3

SVF INVESTMENTS (UK) LTD

SOFTBANK VISION FUND L.P.

SVF GP (JERSEY) LTD

SVF HOLDINGS (UK) LLP

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
0 2019-07-10 3

VIKING GLOBAL INVESTORS LP

VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP

VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

VIKING GLOBAL OPPORTUNITIES GP LLC

HALVORSEN OLE ANDREAS

OTT DAVID C.

SHABET ROSE SHARON

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
0 2019-07-10 3

DEXXON HOLDINGS LTD.

DEXCEL PHARMA TECHNOLOGIES LTD.

OREN DAN

  • SEE REMARKSSEE REMARKSSEE REMARKS
0 2019-07-10 2

VIKING GLOBAL PERFORMANCE LLC

VIKING GLOBAL EQUITIES LP

VIKING GLOBAL EQUITIES II LP

VGE III PORTFOLIO LTD.

VIKING GLOBAL EQUITIES MASTER LTD.

VIKING LONG FUND GP LLC

VIKING LONG FUND MASTER LTD.

HALVORSEN OLE ANDREAS

OTT DAVID C.

SHABET ROSE SHARON

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
0 2019-07-10 2

QVT ASSOCIATES GP LLC

QVT FINANCIAL INVESTMENT CAYMAN LTD.

  • 10% Owner
0 2019-07-10 2

JEFFS ROGER

  • Director
103,532 2019-07-03 1

PANDE ATUL

  • Director
0 2019-06-27 2

SUNDARAM SENTHIL VEL

  • Director
0 2019-06-27 2

ROIVANT SCIENCES LTD.

  • 10% Owner
22,860,013 2019-06-17 2

FALBERG KATHRYN E

  • Director
162,610 2019-06-13 0

OLANOFF LAWRENCE S

  • Director
58,259 2019-06-05 0

HUNG DAVID

  • Director
0 2019-06-03 0

PISANO GARY P.

  • Director
0 2019-05-22 0

MODIG BERNDT

  • Director
0 2019-04-15 1

BAZLEY MATHEW C. GENERAL COUNSEL

  • Officer
0 2019-04-15 1

VIKING GLOBAL EQUITIES MASTER LTD.

  • 10% Owner
22,703,669 2019-01-01 1

QVT ASSOCIATES GP LLC

QVT OFFSHORE LTD.

  • 10% Owner
99,285,714 2018-12-18 2

VIKING GLOBAL PERFORMANCE LLC

VIKING GLOBAL EQUITIES LP

VIKING GLOBAL EQUITIES II LP

VGE III PORTFOLIO LTD.

VIKING LONG FUND MASTER LTD.

VIKING LONG FUND GP LLC

HALVORSEN OLE ANDREAS

OTT DAVID C.

SHABET ROSE SHARON

  • 10% Owner
99,285,714 2018-12-18 2

MCCOURT MARION SVP COMMERCIAL

  • Officer
12,500 2018-12-12 0

ADASCZIK MICHAEL VP, CHIEF ACCOUNTING OFFICER

  • Officer
0 2018-11-12 0

VIKING GLOBAL PERFORMANCE LLC

VIKING GLOBAL EQUITIES LP

VIKING GLOBAL EQUITIES II LP

VGE III PORTFOLIO LTD.

VIKING LONG FUND GP LLC

VIKING LONG FUND MASTER LTD.

  • 10% Owner
22,703,669 2018-10-01 2

ALTMEYER MARK

  • Director
0 2018-08-31 0

LOMBARDO ILISE CHIEF MEDICAL OFFICER

  • Officer
0 2018-08-15 0

RAMASWAMY VIVEK

  • Director
0 2018-06-19 0

OREN ILAN

  • Director
0 2018-06-06 0

WEINHOFF GREGORY M PRINCIPAL FINANCIAL OFFICER

  • Officer
0 2018-03-15 0

MOHR STEPHEN FREDERICK GENERAL COUNSEL

  • Officer
0 2018-03-15 0

DEXCEL PHARMA TECHNOLOGIES LTD.

  • 10% Owner
16,013,540 2017-09-06 0

SHABET ROSE SHARON

  • 10% Owner
75,000,000 2017-07-01 0

FRIEDHOFF LAWRENCE MD PHD CHIEF DEVELOPMENT OFFICER

  • Officer
0 2017-04-28 0

ROMEO MARIANNE L. HEAD,GLOBAL TRANS. & RISK MGMT

  • Officer
0 2016-10-26 0

DEXXON HOLDINGS LTD.

OREN DAN

  • 10% Owner
37,231,342 2016-10-26 0

VIKING GLOBAL INVESTORS LP

VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP

VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

VIKING GLOBAL OPPORTUNITIES GP LLC

HALVORSEN OLE ANDREAS

OTT DAVID C.

SUNDHEIM DANIEL S.

  • 10% Owner
37,231,342 2016-10-26 0

CVIJIC CHRISTINE MIKAIL CHIEF ADMIN OFFICER AND GC

  • Officer
0 2016-04-29 0

ROEMER ALAN S. PRINCIPAL FIN & ACCT OFFICER

  • Officer
0 2015-06-10 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

CORCORAN GAVIN - Officer EVP OF R&D

2019-09-21 A 32,003 a 32,003 0.00 direct

CHERUVU PAVAN - Officer PRINCIPAL EXECUTIVE OFFICER

2019-09-21 A 45,181 a 45,181 0.00 direct

NASSIF DAVID W. - Officer PRINCIPAL FINANCIAL OFFICER

2019-09-21 A 30,120 a 30,120 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments